Menu
Currency
GWAS Study

Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.

Clark SL, Adkins DE, Aberg K et al.

22041458 PubMed ID
GWAS Study Type
1439 Participants
42 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CS
Clark SL
AD
Adkins DE
AK
Aberg K
HJ
Hettema JM
MJ
McClay JL
SR
Souza RP
VD
van den Oord EJ
Chapter II

Abstract

Summary of the research findings

Understanding individual differences in susceptibility to antidepressant therapy side-effects is essential to optimize the treatment of depression.

1,151 European ancestry cases, 288 African American cases

Chapter III

Study Statistics

Key metrics and study information

1439
Total Participants
GWAS
Study Type
No
Replicated
European, African American or Afro-Caribbean
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.